← Eichor
Study identifier: NCT05880641 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Use of Shockwave M5+/L6 IVL Catheter (Intravascular Lithotripsy) in Hostile and Calcified Iliac Access

Condition: Aortic Diseases · Aorto-Iliac Atherosclerosis · Peripheral Arterial Disease  ·  Sponsor: EndoCore Lab s.r.l.

PhaseN/A
Planned participants40
Who can joinAll sexes, 18 Years to no upper limit
Healthy volunteersNo

About this study

The study will evaluate, in a controlled setting, the efficacy and safety of the intravascular lithotripsy using Shockwave™ M5+/L6 Peripheral Intravascular Lithotripsy Catheter to facilitate delivery of aortic large-bore devices in iliac calcified access.

This description comes directly from the study's public registry record.

Talk to the study team

Daniela Ramaccini, PhD, PharmD  ·  +39 3534390426  ·  d.ramaccini@endocorelab.org

Stefano Fazzini, MD  ·  +39 06 20902 833  ·  stefano.fazzini@uniroma2.it

Always discuss trial participation with your own doctor first.

Locations (6)

Azienda Ospedaliero Universitaria delle MarcheAncona, Ancona, ItalyRecruiting
Sant'Orsola HospitalBologna, Emilia-Romagna, ItalyNot Yet Recruiting
Fondazione PTV - Policlinico Tor VergataRome, Lazio, ItalyRecruiting
Ospedale San Giovanni di DioFlorence, Tuscany, ItalyNot Yet Recruiting
Ospedale Santa Maria della Misericordia di PerugiaPerugia, Umbria, ItalyNot Yet Recruiting
Azienda Ospedaliero-Universitaria di PadovaPadova, Veneto, ItalyNot Yet Recruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT05880641